Newport Trust Company’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-6,750,135
Closed -$390M 56
2023
Q4
$390M Sell
6,750,135
-81,701
-1% -$4.72M 1.04% 16
2023
Q3
$361M Sell
6,831,836
-25,336
-0.4% -$1.34M 1.11% 16
2023
Q2
$371M Sell
6,857,172
-60,076
-0.9% -$3.25M 1.08% 17
2023
Q1
$346M Sell
6,917,248
-32,578
-0.5% -$1.63M 0.96% 17
2022
Q4
$322M Sell
6,949,826
-327,668
-5% -$15.2M 0.89% 18
2022
Q3
$282M Sell
7,277,494
-124,323
-2% -$4.82M 0.95% 17
2022
Q2
$276M Buy
7,401,817
+7,258,993
+5,082% +$271M 0.89% 17
2022
Q1
$6.33M Sell
142,824
-7,624,326
-98% -$338M 0.02% 48
2021
Q4
$330M Buy
7,767,150
+108,497
+1% +$4.61M 0.89% 17
2021
Q3
$332M Sell
7,658,653
-236,086
-3% -$10.2M 0.9% 17
2021
Q2
$338M Sell
7,894,739
-443,601
-5% -$19M 0.85% 16
2021
Q1
$322M Sell
8,338,340
-431,357
-5% -$16.7M 0.8% 17
2020
Q4
$315M Buy
8,769,697
+15,864
+0.2% +$570K 0.87% 15
2020
Q3
$334M Sell
8,753,833
-218,453
-2% -$8.35M 1.17% 12
2020
Q2
$315M Sell
8,972,286
-222,393
-2% -$7.81M 1.15% 11
2020
Q1
$300M Sell
9,194,679
-82,291
-0.9% -$2.69M 1.23% 11
2019
Q4
$420M Sell
9,276,970
-386,692
-4% -$17.5M 1.13% 12
2019
Q3
$393M Sell
9,663,662
-183,403
-2% -$7.46M 1.05% 13
2019
Q2
$423M Sell
9,847,065
-375,533
-4% -$16.1M 1.14% 13
2019
Q1
$392M Sell
10,222,598
-155,626
-1% -$5.97M 1.18% 11
2018
Q4
$367M Sell
10,378,224
-38,069
-0.4% -$1.35M 1.19% 12
2018
Q3
$401M Sell
10,416,293
-224,245
-2% -$8.63M 1.11% 12
2018
Q2
$348M Sell
10,640,538
-80,832
-0.8% -$2.64M 1.01% 12
2018
Q1
$293M Sell
10,721,370
-394,337
-4% -$10.8M 0.82% 13
2017
Q4
$276M Buy
+11,115,707
New +$276M 0.77% 16